Home
Theragen Bio

Theragen Bio Market Share Analysis for March 2026

Global genome service provider and AI-based biopharmaceutical company

Health > Medicine

Domaintheragenbio.com

Year Founded2020

Employees51 - 200

Annual Revenue--

Theragen Bio

Theragen Bio (including company regionals)

theragenbio.com

See more website traffic and engagement information

Total visits to Theragen Bio's top domains

Understand Theragen Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

theragenbio.com3.6K

See more with Sales Intelligence

Avg. visit duration in Theragen Bio's top domains

Analyze Theragen Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

theragenbio.com00:00:22

See more with Sales Intelligence

Avg. pageviews on Theragen Bio's top domains

See how Theragen Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

theragenbio.com1.91

See more with Sales Intelligence

Theragen Bio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Theragen Bio

These are the website technologies, by industry, used by Theragen Bio top domains

Widget (4)

Twemoji

Mobile (3)

Meta Viewport

eCommerce (2)

DHL

Advertising (1)

DoubleClick

More Technologies

6

See all

News & Signals from Theragen Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTheragen Bio Co. launched Hellogene 4.0 on Apr 13th '22.Theragen Bio said Wednesday that the company has launched Hellogene 4.0, its newest disease prediction personal genetic test service.

NewsTheragen Bio Co. is developing next-generation cancer vaccine.In Korea, Theragen Bio, ST Pharm, and Celltrion have announced either a plan for cooperation for mRNA technology or an introduction to an mRNA technology platform to develop a next-generation cancer vaccine.

NewsTheragen Bio Co. is developing vaccine for cancers on Jul 20th '21.Theragen Bio said Tuesday that it has obtained a domestic patent for a genetic sequence method to predict neoantigen to develop a vaccine for cancers.